START FREE TRIAL

Technology & AI

Apple’s WWDC Keynote Is Here. The Swing Factor NOBODY Is Writing About Is NOT Siri!

Two years ago Apple showed the world a "new Siri" that barely worked....

Is SpaceX Asking $1.75 Trillion For A Company Truly Worth NO MORE THAN $780 Billion?

The largest IPO in history just launched its roadshow. Here's what Wall Street...

Broadcom Said 3 Words That Killed The Narrative: “WE ARE CHIPS ONLY!”A

Let's do the math quickly. Broadcom (NASDAQ:AVGO) just reported $10.8 billion in AI chip...

M&A

Incyte Acquisition Watch: The $2 Billion Star Therapeutics Deal That Could Change Its Story

Incyte Corporation (NASDAQ:INCY) is back in the biotech deal spotlight. The company is...

Sony Just Made Music IP Look Like A Bigger SHIFT Than Games

Sony Group Corporation (NYSE:SONY) is leaning harder into the business of owning culture,...

Meta Doesn’t Want to Build the Metaverse. It Wants to Build Your Robot

Meta Platforms (NASDAQ:META) just made the kind of acquisition that sounds small until...

Consumer & Retail

Did Ingredion Find A Mispriced Path Into Higher-Value Ingredients?

Ingredion (NYSE:INGR) has moved into deal mode with a recommended all-cash offer to...

Walmart Vs. Target: The Retail Earnings Week That Could Reveal The Real State Of The American Consumer!

Walmart (NYSE:WMT) and Target (NYSE:TGT) are stepping into a retail earnings week that...

Amazon Earnings Pre-Mortem: THIS Is What’s Making Investors Nervous!!

Amazon reports earnings this week, and the setup looks strong on the surface. Consensus...

Premium

Did Ingredion Find A Mispriced Path Into Higher-Value Ingredients?

Ingredion (NYSE:INGR) has moved into deal mode with a recommended all-cash offer to...

Incyte Acquisition Watch: The $2 Billion Star Therapeutics Deal That Could Change Its Story

Incyte Corporation (NASDAQ:INCY) is back in the biotech deal spotlight. The company is...

Apple’s WWDC Keynote Is Here. The Swing Factor NOBODY Is Writing About Is NOT Siri!

Two years ago Apple showed the world a "new Siri" that barely worked....

Healthcare

Incyte Acquisition Watch: The $2 Billion Star Therapeutics Deal That Could Change Its Story

Incyte Corporation (NASDAQ:INCY) is back in the biotech deal spotlight. The company is...

Novo Nordisk Earnings Pre-Mortem: The Beat May Not Be Enough!

Novo Nordisk reports first-quarter 2026 earnings on May 6, and the market is...

Everyone Thinks Eli Lilly Is A Weight-Loss Stock. That’s The Trap

Eli Lilly (NYSE:LLY) is having one of those rare market moments where everyone...

Energy

Exxon’s $5 Billion Gamble: Venezuela Goldmine Or Trap?

Exxon Mobil (NYSE:XOM) may be staring at one of the strangest oil opportunities...

Is NextEra’s Dominion Deal Really An AI Power Grab?

NextEra Energy (NYSE:NEE) is reportedly in advanced talks to acquire Dominion Energy (NYSE:D),...

The $180 Oil Scenario: What A Prolonged Oil Shock Could Mean For Chevron Vs. Exxon

The latest oil move has been driven less by ordinary commodity tightening and...

Industrials

BorgWarner’s AI Pivot Is Powering A Re-Rating — But Where Could The Story Crack?

BorgWarner has quietly engineered one of the more dramatic sentiment reversals in the...

Did The Rio Tinto–Glencore Deal Fail Because Copper Is TOO Strategic?

Rio Tinto and Glencore walked away from merger talks that would have reshaped...

Howmet Buys CAM: The $1.8 Billion Bet That Could Reshape Aerospace

On December 22, 2025, Howmet Aerospace (NYSE:HWM) announced plans to acquire Consolidated Aerospace...

Miscellaneous

The Saaspocalypse Narrative Is Not Dead; But It Just Lost Its Most Important Assumption!

Two software earnings reports landed in the same week and collectively produced the...

Toms Capital Just Put McCormick’s Flavor Empire In Focus

McCormick & Company (NYSE:MKC) is not usually the kind of stock that screams...